Skip to main content
. Author manuscript; available in PMC: 2009 Jul 3.
Published in final edited form as: Expert Rev Anticancer Ther. 2009 May;9(5):597–612. doi: 10.1586/era.09.22

Box 2.

Summary of mesenchymal stem cell therapies for gliomas.

Chemotherapeutic vehicles
• HSV-thymidine kinase [172]
Viral delivery vehicles
• Conditionally replicating adenovirus [173]
Immunotherapeutic vehicles
• IL-2 [34,174,175]
• IL-18 [176]
• IL-23 [124]
• TRAIL [177]
• IFN-α [178]
• IFN-β [36]

HSV: Herpes simplex virus; TRAIL: TNF-related apoptosis-inducing ligand.